Nexalin Technology Inc Revenue Growth Rates (NXL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Nexalin Technology Inc   (NASDAQ: NXL)
 

NXL's Revenue Growth by Quarter and Year

Nexalin Technology Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NXL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.01
1st Quarter March 0.01
FY 0.02





NXL Revenue second quarter 2026 Y/Y Growth Comment
Nexalin Technology Inc reported drop in Revenue in the second quarter 2026 by -82.63% to $ 0.01 millions, from the same quarter in 2025.
The fall in the second quarter 2026 Nexalin Technology Inc 's Revenue compares unfavorably to the Company's average Revenue decrease of -6.35%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 30 other companies have achieved higher Revenue growth. While Nexalin Technology Inc ' s Revenue meltdown of -82.63% ranks overall at the positon no. 508 in the second quarter 2026.


NXL Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 466.67 % 50 % -50 %
3rd Quarter September - -50 % 100 % -96.36 %
2nd Quarter June -82.63 % 133.33 % -25 % -90.24 %
1st Quarter March -75 % -50 % 166.67 % -90.63 %
FY   - 66.67 % 63.64 % -

Financial Statements
Nexalin Technology Inc 's second quarter 2026 Revenue $ 0.01 millions NXL's Income Statement
Nexalin Technology Inc 's second quarter 2025 Revenue $ 0.07 millions Quarterly NXL's Income Statement


NXL Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 750 % -25 % 0 %
3rd Quarter September - -71.43 % 33.33 % -50 %
2nd Quarter June 21.61 % 75 % -62.5 % 33.33 %
1st Quarter March -94.12 % 33.33 % 300 % -25 %
FY (Year on Year)   - 66.67 % 63.64 % -


Back to NXL Growth rate Comparisons >> Back to NXL Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #120
Overall #508

Revenue Y/Y Growth Statistics
High Average Low
110.26 % -6.35 % -91.62 %
(Mar 31 2026)   (Dec 31 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #120
Overall #508
Revenue Y/Y Growth Statistics
High Average Low
110.26 % -6.35 % -91.62 %
(Mar 31 2026)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Nexalin Technology Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
847.13 % 65.92 % -92.95 %
(Dec 31 2025)  


NXL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Nexalin Technology Inc disclosed rise in Revenue from the first quarter by 21.61% to $ 0.01 millions, from $ 0.01 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 185 other companies have achieved higher Revenue quarter on quarter growth. While Nexalin Technology Inc 's Revenue growth quarter on quarter, overall rank is 3885.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #186
Healthcare Sector #583
Overall #3885
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #186
Healthcare Sector #583
Overall #3885
Revenue Q/Q Growth Statistics
High Average Low
847.13 % 65.92 % -92.95 %
(Dec 31 2025)  


NXL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Nexalin Technology Inc disclosed rise in Revenue from the first quarter by 21.61% to $ 0.01 millions, from $ 0.01 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 185 other companies have achieved higher Revenue quarter on quarter growth. While Nexalin Technology Inc 's Revenue growth quarter on quarter, overall rank is 3885.


Nexalin Technology Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.22 $ 0.28 $ 0.30 $ 0.16 $ 0.17
Y / Y Revenue Growth (TTM) 24.22 % 110.26 % 78.78 % -3.18 % 16.42 %
Year on Year Revenue Growth Overall Ranking # 1037 # 69 # 116 # 0 # 0
Seqeuential Revenue Change (TTM) -21.2 % -8.64 % 92.22 % -10.23 % 33.38 %
Seq. Revenue Growth (TTM) Overall Ranking # 508 # 2828 # 2965 # 2819 # 0


Cumulative Revenue growth Comment
Assuming the Nexalin Technology Inc 's fiscal year would have ended in Jun 30 2026, Nexalin Technology Inc would have reprted above average annual Revenue rise of 24.22% year on year, of $ 0 millions.
This marks a slow-down of the companys growth trends and from the 110.26% surge in Mar 31 2026.

In the Healthcare sector 196 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 69 to 1037.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 31
Healthcare Sector # 197
Overall # 1037

Revenue TTM Y/Y Growth Statistics
High Average Low
110.26 %
 -6.35 %
-91.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 120
S&P 500 # 508
Cumulative Revenue growth Comment
Assuming the Nexalin Technology Inc 's fiscal year would have ended in Jun 30 2026, Nexalin Technology Inc would have reprted above average annual Revenue rise of 24.22% year on year, of $ 0 millions.
This marks a slow-down of the companys growth trends and from the 110.26% surge in Mar 31 2026.

In the Healthcare sector 196 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 69 to 1037.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 31
Healthcare Sector # 197
Overall # 1037

Revenue TTM Y/Y Growth Statistics
High Average Low
110.26 %
-6.35 %
-91.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 120
S&P 500 # 508




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NXL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Nexalin Technology Inc Revenue Growth Rates (NXL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Nexalin Technology Inc (CIK 1527352).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001829126-26-008709
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Nexalin Technology Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.